How to improve clinical research in a department of radiation oncology
Autor: | Elisabeth Daguenet, Claire Bosacki, Wafa Bouleftour, Sandrine Sotton, Safa Louati, Nicolas Magné, Samuel Gessen, Mathilde Gras |
---|---|
Přispěvatelé: | Institut de Physique Nucléaire de Lyon (IPNL), Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Physique Nucléaire et de Physique des Particules du CNRS (IN2P3) |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Cancer Research medicine.medical_specialty Biomedical Research medicine.medical_treatment Radiotherapy department Radiotherapy unit 03 medical and health sciences 0302 clinical medicine Neoplasms Radiation oncology Medicine Humans Radiology Nuclear Medicine and imaging Medical physics [PHYS]Physics [physics] Clinical Trials as Topic business.industry Cancer Hematology General Medicine medicine.disease 3. Good health Radiation therapy Clinical trial 030104 developmental biology Clinical research Oncology 030220 oncology & carcinogenesis Radiation Oncology Observational study business |
Zdroj: | Bull.Cancer Bull.Cancer, 2020, 107 (10), pp.991-998. ⟨10.1016/j.bulcan.2020.06.007⟩ |
ISSN: | 1769-6917 |
Popis: | Summary Introduction Radiation therapy is a core modality for cancer treatment. Around 40% of cancer cures include the use of radiotherapy, either as a single strategy or combined with other treatments. In the past decade, substantial technical advances and novel insights into radiobiological properties have considerably improved patients’ outcomes. This study overviewed the landscape of clinical research at our radiotherapy department. Methods We surveyed our institutional database of clinical trials to collect information for completed or ongoing radiation therapy clinical trials, from 2005 to December 2017 at the Lucien Neuwirth cancer institute. Results A total of 31 clinical trials were undertaken during the study period, of which 4 studies (12.9%) were industry-sponsored and 3 studies (9.7%) were launched by our radiotherapy unit. The vast majority of clinical trials (83.9%) were dedicated to unique organ localization, especially urological cancer (prostate or bladder) (42%). We also observed a shift towards more phase II trials during the study period as well as a special focus on elderly population. Over the last decade, the number of included patients increased by a 5.3 fold input, with 135 inclusions before 2011 and 720 inclusions after 2011. Discussion This study provided an observational and comprehensive analysis of radiotherapy research. From a monocentric point-of-view, these results reflected the on-going progress of worldwide radiotherapy research. Based on a 13-years’ experience, this study aimed at highlighting essential cues to ensure efficient and perennial research. |
Databáze: | OpenAIRE |
Externí odkaz: |